LeonaBio (LONA) Other Non-Current Assets (2020 - 2026)
LeonaBio (LONA) reported Other Non-Current Assets of $631000.0 for Q1 2026, little changed year-over-year from $631000.0 in Q1 2025, and little changed on a QoQ basis from $631000.0 in Q4 2025.
LeonaBio (LONA) has 7 years of Other Non-Current Assets data on file, last reported at $631000.0 in Q1 2026.
- Quarterly Other Non-Current Assets changed 0.0% year-over-year to $631000.0 in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $631000.0 (changed 0.0% YoY) and the FY2025 annual result came in at $631000.0, changed 0.0% from the prior year.
- Other Non-Current Assets steadied at $631000.0 in Q1 2026 per LONA's latest filing, from $631000.0 in the prior quarter.
- Across five years, Other Non-Current Assets topped out at $631000.0 in Q3 2023 and bottomed at $55000.0 in Q3 2022.
- The 5-year median for Other Non-Current Assets is $420000.0 (2022), against an average of $368000.0.
- The widest annual swing landed in 2023, when Other Non-Current Assets jumped 1047.27%; it then tumbled 91.28% in 2024.
- Tracing LONA's Other Non-Current Assets over 5 years: stood at $420000.0 in 2022, then surged by 50.24% to $631000.0 in 2023, then changed by 0.0% to $631000.0 in 2024, then changed by 0.0% to $631000.0 in 2025, then changed by 0.0% to $631000.0 in 2026.
- Per Business Quant, the three latest LONA Other Non-Current Assets figures stand at $631000.0 (Q1 2026), $631000.0 (Q4 2025), and $55000.0 (Q3 2025).
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Other Non-Current Assets (Qtr) |
|---|---|---|---|---|---|
| 1 | Quantum Biopharma | 1,216,509.61 Bn | 1,216,509.61 Bn | - | - |
| 2 | Alterity Therapeutics | 764,224.41 Bn | 764,224.38 Bn | - | - |
| 3 | Legend Biotech | 2,716.00 Bn | 2,715.71 Bn | 242.10 Mn | 12.40 Mn |
| 4 | Nanobiotix | 2,248.83 Bn | 2,248.77 Bn | - | - |
| 5 | Akari Therapeutics | 1,951.18 Bn | 1,951.17 Bn | - | 60,000.00 |
| 6 | Vertex Pharmaceuticals | 113.69 Bn | 106.44 Bn | 2.59 Bn | 1.26 Bn |
| 7 | Evaxion A | 64.16 Bn | 64.14 Bn | - | - |
| 8 | Regeneron Pharmaceuticals | 63.94 Bn | 55.18 Bn | 3.31 Bn | 2.13 Bn |
| 9 | Alnylam Pharmaceuticals | 40.13 Bn | 37.12 Bn | 959.66 Mn | 63.55 Mn |
| 10 | LeonaBio | 181.52 Mn | 113.84 Mn | - | 631,000.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 631,000.00 |
| Dec 31, 2025 | 631,000.00 |
| Sep 30, 2025 | 55,000.00 |
| Jun 30, 2025 | 631,000.00 |
| Mar 31, 2025 | 631,000.00 |
| Dec 31, 2024 | 631,000.00 |
| Sep 30, 2024 | 55,000.00 |
| Jun 30, 2024 | 55,000.00 |
| Mar 31, 2024 | 631,000.00 |
| Dec 31, 2023 | 631,000.00 |
| Sep 30, 2023 | 631,000.00 |
| Jun 30, 2023 | 61,000.00 |
| Mar 31, 2023 | 72,000.00 |
| Dec 31, 2022 | 420,000.00 |
| Sep 30, 2022 | 55,000.00 |
| Jun 30, 2022 | 210,000.00 |
| Mar 31, 2022 | 225,000.00 |
| Dec 31, 2021 | 56,000.00 |
| Sep 30, 2021 | 125,000.00 |
| Jun 30, 2021 | 225,000.00 |
| Mar 31, 2021 | 55,000.00 |
| Dec 31, 2020 | 132,000.00 |
| Sep 30, 2020 | 55,000.00 |